Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tullio Sulser

Showing results (1-10 of 180) with videos related to

Pageof 18
Sort By:
European Urology|October 16, 2007
Is kidney surgery going to be minimally invasive in all cases?Tullio Sulser
Praxis|November 26, 2015
[Erectile and Ejaculatory Dysfunction]Oliver Gross, Tullio Sulser, Daniel Eberli
Praxis|April 2, 2014
[Focal therapy-a new era in the treatment of prostate cancer]Daniel Eberli, Ashkan Mortezavi, Tullio Sulser
World Journal of Urology|May 16, 2008
Intraoperative complications of laparoscopic adrenalectomyRaeto T Strebel, Michael Müntener, Tullio Sulser
Urologia Internationalis|December 10, 2009
Delayed infection of a pelvic lymphocele following robotic radical prostatectomy and pelvic lymphadenectomy: two casesMathias Tremp, Tullio Sulser, Hans-Helge Seifert
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 29, 2011
Artificial prostate-specific antigen persistence after radical prostatectomyCédric Poyet, Danielle Hof, Tullio Sulser, et al.
The Journal of Urology|July 13, 2004
Long-term experience with surgical and conservative treatment of penile fractureMichael Muentener, Stefan Suter, Dieter Hauri, et al.
International Journal of Colorectal Disease|September 5, 2014
A novel animal model for external anal sphincter insufficiencyLukas Brügger, Roman Inglin, Daniel Candinas, et al.
Urologic Oncology|May 30, 2020
Apalutamide in combination with autophagy inhibitors improves treatment effects in prostate cancer cellsDaniel Eberli, Benedikt Kranzbühler, Ashkan Mortezavi, et al.
The Prostate|October 23, 2018
Combined N-terminal androgen receptor and autophagy inhibition increases the antitumor effect in enzalutamide sensitive and enzalutamide resistant prostate cancer cellsBenedikt Kranzbühler, Souzan Salemi, Ashkan Mortezavi, et al.
Pageof 18

Showing results (1-10 of 180) with videos related to

Sort By:
Pageof 18
European Urology|October 16, 2007
Is kidney surgery going to be minimally invasive in all cases?Tullio Sulser
Praxis|November 26, 2015
[Erectile and Ejaculatory Dysfunction]Oliver Gross, Tullio Sulser, Daniel Eberli
Praxis|April 2, 2014
[Focal therapy-a new era in the treatment of prostate cancer]Daniel Eberli, Ashkan Mortezavi, Tullio Sulser
World Journal of Urology|May 16, 2008
Intraoperative complications of laparoscopic adrenalectomyRaeto T Strebel, Michael Müntener, Tullio Sulser
Urologia Internationalis|December 10, 2009
Delayed infection of a pelvic lymphocele following robotic radical prostatectomy and pelvic lymphadenectomy: two casesMathias Tremp, Tullio Sulser, Hans-Helge Seifert
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 29, 2011
Artificial prostate-specific antigen persistence after radical prostatectomyCédric Poyet, Danielle Hof, Tullio Sulser, et al.
The Journal of Urology|July 13, 2004
Long-term experience with surgical and conservative treatment of penile fractureMichael Muentener, Stefan Suter, Dieter Hauri, et al.
International Journal of Colorectal Disease|September 5, 2014
A novel animal model for external anal sphincter insufficiencyLukas Brügger, Roman Inglin, Daniel Candinas, et al.
Urologic Oncology|May 30, 2020
Apalutamide in combination with autophagy inhibitors improves treatment effects in prostate cancer cellsDaniel Eberli, Benedikt Kranzbühler, Ashkan Mortezavi, et al.
The Prostate|October 23, 2018
Combined N-terminal androgen receptor and autophagy inhibition increases the antitumor effect in enzalutamide sensitive and enzalutamide resistant prostate cancer cellsBenedikt Kranzbühler, Souzan Salemi, Ashkan Mortezavi, et al.
Pageof 18